GE HealthCare Technologies (GEHC) Projected to Post Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) is projected to post its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect the company to announce earnings of $1.05 per share and revenue of $5.0735 billion for the quarter. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS.Investors can find conference call details on the company's upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Wednesday, October 29, 2025 at 8:30 AM ET.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. The firm had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company's revenue was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.00 EPS. On average, analysts expect GE HealthCare Technologies to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.

GE HealthCare Technologies Trading Up 0.8%

GEHC opened at $76.10 on Wednesday. The firm has a market cap of $34.74 billion, a price-to-earnings ratio of 15.59, a PEG ratio of 2.88 and a beta of 1.13. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The stock has a fifty day moving average price of $74.60 and a 200-day moving average price of $72.16. GE HealthCare Technologies has a 12 month low of $57.65 and a 12 month high of $94.80.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio is presently 2.87%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on GEHC. Barclays initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They issued an "equal weight" rating and a $86.00 target price for the company. Wall Street Zen downgraded shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a report on Saturday, September 20th. Zacks Research cut shares of GE HealthCare Technologies from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 29th. Citigroup downgraded shares of GE HealthCare Technologies from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $93.00 to $83.00 in a research report on Tuesday, October 7th. Finally, Morgan Stanley set a $74.00 target price on GE HealthCare Technologies in a research report on Thursday, September 18th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $85.20.

Hedge Funds Weigh In On GE HealthCare Technologies

Hedge funds have recently bought and sold shares of the business. Tower Research Capital LLC TRC increased its position in shares of GE HealthCare Technologies by 64.7% in the second quarter. Tower Research Capital LLC TRC now owns 15,798 shares of the company's stock valued at $1,170,000 after buying an additional 6,207 shares in the last quarter. Vident Advisory LLC grew its stake in GE HealthCare Technologies by 16.5% in the 2nd quarter. Vident Advisory LLC now owns 10,733 shares of the company's stock valued at $795,000 after acquiring an additional 1,522 shares during the period. Snowden Capital Advisors LLC grew its stake in GE HealthCare Technologies by 88.6% in the 2nd quarter. Snowden Capital Advisors LLC now owns 9,011 shares of the company's stock valued at $667,000 after acquiring an additional 4,232 shares during the period. Cresset Asset Management LLC increased its holdings in GE HealthCare Technologies by 12.5% in the 2nd quarter. Cresset Asset Management LLC now owns 7,802 shares of the company's stock worth $578,000 after acquiring an additional 865 shares in the last quarter. Finally, IHT Wealth Management LLC raised its position in GE HealthCare Technologies by 4.8% during the second quarter. IHT Wealth Management LLC now owns 7,640 shares of the company's stock worth $566,000 after acquiring an additional 347 shares during the period. Hedge funds and other institutional investors own 82.06% of the company's stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.